Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Penetration of Drugs through the Blood-Cerebrospinal Fluid/Blood-Brain Barrier for Treatment of Central Nervous System Infections
- R. Nau, F. Soergel, H. Eiffert
- Biology, Medicine
- Clinical Microbiology Reviews
- 1 October 2010
SUMMARY The entry of anti-infectives into the central nervous system (CNS) depends on the compartment studied, molecular size, electric charge, lipophilicity, plasma protein binding, affinity to… Expand
Toxicokinetics of Acrylamide in Humans after Ingestion of a Defined Dose in a Test Meal to Improve Risk Assessment for Acrylamide Carcinogenicity
- U. Fuhr, M. I. Boettcher, +13 authors E. Schömig
- Chemistry, Medicine
- Cancer Epidemiology Biomarkers & Prevention
- 1 February 2006
High amounts of acrylamide in some foods result in an estimated daily mean intake of 50 μg for a western style diet. Animal studies have shown the carcinogenicity of acrylamide upon oral exposure.… Expand
Population Pharmacokinetics and Pharmacodynamics of Continuous versus Short-Term Infusion of Imipenem-Cilastatin in Critically Ill Patients in a Randomized, Controlled Trial
- S. Sakka, A. Glauner, +4 authors F. Soergel
- Medicine
- Antimicrobial Agents and Chemotherapy
- 1 September 2007
ABSTRACT Beta-lactams are regularly administered in intermittent short-term infusions. The percentage of the dosing interval during which free drug concentrations exceed the MIC (fT>MIC) is the… Expand
Passage of cefotaxime and ceftriaxone into cerebrospinal fluid of patients with uninflamed meninges.
- R. Nau, H. Prange, +4 authors F. Soergel
- Medicine
- Antimicrobial Agents and Chemotherapy
- 1 July 1993
Cefotaxime and ceftriaxone have proven to be effective in pyogenic infections of the central nervous system. Since in some bacterial central nervous system infections the blood-cerebrospinal fluid… Expand
Acrylamide: Increased Concentrations in Homemade Food and First Evidence of Its Variable Absorption from Food, Variable Metabolism and Placental and Breast Milk Transfer in Humans
- F. Soergel, R. Weissenbacher, +4 authors C. Landersdorfer
- Chemistry, Medicine
- Chemotherapy
- 2002
We have developed a liquid chromatography/mass spectrometry (LC-MS/MS) assay to determine acrylamide in various body fluids. The assay also allows the reliable quantitation of acrylamide in food. In… Expand
The chemistry, pharmacokinetics and tissue distribution of piperacillin/tazobactam.
- F. Soergel, M. Kinzig
- Chemistry, Medicine
- The Journal of antimicrobial chemotherapy
- 1993
The pharmacokinetic properties of piperacillin/tazobactam are summarized. The data on piperacillin show that the behaviour of this well established agent is the same when given in combination with… Expand
Inhibitory potency of quinolone antibacterial agents against cytochrome P450IA2 activity in vivo and in vitro.
- U. Fuhr, E. Anders, G. Mahr, F. Soergel, A. Staib
- Chemistry, Medicine
- Antimicrobial Agents and Chemotherapy
- 1 May 1992
Inhibition of cytochrome P450IA2 activity is an important adverse effect of quinolone antibacterial agents. It results in a prolonged half-life for some drugs that are coadministered with quinolones,… Expand
Penetration of antibacterials into bone: pharmacokinetic, pharmacodynamic and bioanalytical considerations.
- C. Landersdorfer, J. Bulitta, M. Kinzig, U. Holzgrabe, F. Soergel
- Medicine
- Clinical pharmacokinetics
- 2009
Antibacterials play a key role in the treatment of bone infections and appropriate surgical prophylaxis. The rate and extent of penetration of antimicrobials into bone has been assessed and shown to… Expand
Bioequivalence of HX575 (recombinant human epoetin alfa) and a comparator epoetin alfa after multiple intravenous administrations: an open-label randomised controlled trial
- F. Soergel, U. Thyroff-Friesinger, A. Vetter, B. Vens-Cappell, M. Kinzig
- Medicine
- BMC clinical pharmacology
- 22 May 2009
BackgroundHX575 is a human recombinant epoetin alfa that was approved for use in Europe in 2007 under the European Medicines Agency biosimilar approval pathway. Therefore, in order to demonstrate the… Expand
N-glycosylation heterogeneity and the influence on structure, function and pharmacokinetics of monoclonal antibodies and Fc fusion proteins.
- Fabian Higel, A. Seidl, F. Soergel, W. Frieß
- Medicine
- European journal of pharmaceutics and…
- 1 March 2016
Monoclonal antibody and Fc fusion protein drugs are complex heterogeneous mixtures of numerous different protein variants and modifications. N-glycosylation as one of the most complex… Expand